XXXX in pediatric intensive care unit.

@entity1 @entity64 @entity63 @entity532 @entity385
@entity532 are being frequently recognized in the pediatric intensive care unit in the recent few years. The epidemiology and risk factors for @entity64 are different from that of the adults. The incidence of @entity385 is almost slightly more than that of @entity64 . The list of diagnostic causes is increasing with the availability of newer imaging modalities and laboratory tests. The diagnostic work up depends on the age of the @entity1 and the rapidity of presentation. Magnetic resonance imaging, computerized tomography and arteriography and venography are the mainstay of diagnosis and to differentiate between @entity63 and hemorrhagic events. Very sophisticated molecular diagnostic tests are required in a very few @entity1 . There are very few pediatric studies on the management of @entity64 . General supportive management is as important as the specific treatment. Most of the treatment guidelines and suggestions are extrapolated from the adult studies. Few guidelines are available for the use of anticoagulants and thrombolytic agents in pediatric @entity1 . So, our objective was to review the available literature on the childhood @entity64 and to provide an insight into the subject for the pediatricians and critical care providers.
